Ming Zhou

17.4k total citations · 1 hit paper
211 papers, 10.3k citations indexed

About

Ming Zhou is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Rheumatology. According to data from OpenAlex, Ming Zhou has authored 211 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 160 papers in Pulmonary and Respiratory Medicine, 66 papers in Molecular Biology and 52 papers in Rheumatology. Recurrent topics in Ming Zhou's work include Prostate Cancer Treatment and Research (80 papers), Prostate Cancer Diagnosis and Treatment (77 papers) and Renal cell carcinoma treatment (67 papers). Ming Zhou is often cited by papers focused on Prostate Cancer Treatment and Research (80 papers), Prostate Cancer Diagnosis and Treatment (77 papers) and Renal cell carcinoma treatment (67 papers). Ming Zhou collaborates with scholars based in United States, China and Canada. Ming Zhou's co-authors include Cristina Magi‐Galluzzi, Mark A. Rubin, Rajal B. Shah, Jonathan I. Epstein, Brian I. Rini, Brian R. Lane, Eric A. Klein, Brett Delahunt, Andrew C. Novick and Paul Elson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ming Zhou

206 papers receiving 10.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia

2013 738 citations John R. Srigley, Brett Delahunt et al. The American Journal of Surgical Pathology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ming Zhou	7.2k	4.5k	2.3k	1.9k	1.7k	211	10.3k
Cristina Magi‐Galluzzi	7.5k 1.1×	3.3k 0.7×	2.1k 0.9×	1.9k 1.0×	1.6k 0.9×	225	10.0k
Satish K. Tickoo	7.5k 1.0×	6.6k 1.5×	3.2k 1.4×	3.5k 1.9×	2.3k 1.3×	187	11.9k
Mitchell C. Benson	8.6k 1.2×	3.9k 0.9×	2.2k 0.9×	3.1k 1.6×	2.8k 1.6×	268	13.3k
Matteo Brunelli	5.1k 0.7×	3.5k 0.8×	2.2k 1.0×	1.4k 0.7×	2.5k 1.4×	379	8.3k
Daniel M. Berney	5.5k 0.8×	3.6k 0.8×	2.4k 1.0×	3.7k 1.9×	1.6k 0.9×	250	10.2k
Ronit Simantov	4.3k 0.6×	5.5k 1.2×	2.6k 1.1×	782 0.4×	3.3k 1.9×	88	11.2k
Jesse K. McKenney	4.0k 0.6×	2.3k 0.5×	965 0.4×	2.4k 1.3×	1.4k 0.8×	183	7.4k
John N. Eble	10.5k 1.5×	9.4k 2.1×	3.9k 1.7×	4.8k 2.5×	2.8k 1.6×	290	17.2k
Christian P. Pavlovich	5.3k 0.7×	3.2k 0.7×	1.1k 0.5×	1.6k 0.9×	804 0.5×	211	7.5k
Gregor Weirich	4.3k 0.6×	3.1k 0.7×	1.3k 0.5×	907 0.5×	1.2k 0.7×	121	7.5k

Countries citing papers authored by Ming Zhou

Since Specialization

Citations

This map shows the geographic impact of Ming Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Zhou more than expected).

Fields of papers citing papers by Ming Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Zhou. The network helps show where Ming Zhou may publish in the future.

Co-authorship network of co-authors of Ming Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Zhou. A scholar is included among the top collaborators of Ming Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Zhou. Ming Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johansson, Dorota, et al.. (2023). Evaluation of A Computer-Aided Detection Software for Prostate Cancer Prediction: Excellent Diagnostic Accuracy Independent of Preanalytical Factors. Laboratory Investigation. 103(12). 100257–100257. 2 indexed citations

Zhou, Ming, et al.. (2023). Intraductal Carcinoma of the Prostate: To Grade or Not to Grade. Cancers. 15(22). 5319–5319. 1 indexed citations

Zhou, Ming, Fangqin Li, Jialin Dai, et al.. (2023). DEL-1 suppression attenuates atherosclerosis by modulating macrophagic GSK-3β/CEBP-β signaling pathway. International Journal of Cardiology. 376. 115–124. 8 indexed citations

Kench, James G., Mahul B. Amin, Daniel M. Berney, et al.. (2022). WHOClassification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer. Histopathology. 81(4). 447–458. 26 indexed citations

Zhou, Ming, et al.. (2022). Rapid subcutaneous progression after immunotherapy in pretreated patients with metastatic carcinoma: two case reports. Journal of International Medical Research. 50(4). 3629155202–3629155202.

Lobo, João, Riuko Ohashi, Mahul B. Amin, et al.. (2022). WHO 2022 landscape of papillary and chromophobe renal cell carcinoma. Histopathology. 81(4). 426–438. 61 indexed citations

Zhang, Anyu, et al.. (2022). Effects of subanaesthetic S-ketamine on postoperative delirium and cognitive function in elderly patients undergoing non-cardiac thoracic surgery: a protocol for a randomised, double-blinded, placebo-controlled and positive-controlled, non-inferiority trial (SKED trial). BMJ Open. 12(8). e061535–e061535. 12 indexed citations

Hu, Chunyan, Manli Wang, Miao Hu, et al.. (2022). Genistein induces endocrine resistance in human breast cancer by suppressing H3K27 trimethylation. Endocrine Related Cancer. 30(2). 9 indexed citations

Delahunt, Brett, John R. Srigley, Meagan Judge, et al.. (2018). Data set for the reporting of carcinoma of renal tubular origin: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 74(3). 377–390. 13 indexed citations

10.

Deng, Fang-Ming, Hongying Huang, Peng Lee, et al.. (2018). Prostate Cancers Detected by Magnetic Resonance Imaging–Targeted Biopsies Have a Higher Percentage of Gleason Pattern 4 Component and Are Less Likely to Be Upgraded in Radical Prostatectomies. Archives of Pathology & Laboratory Medicine. 143(1). 86–91. 8 indexed citations

11.

Kenigsberg, Alexander P., Tsutomu Tamada, Andrew B. Rosenkrantz, et al.. (2017). Multiparametric magnetic resonance imaging identifies significant apical prostate cancers. British Journal of Urology. 121(2). 239–243. 14 indexed citations

12.

Egevad, Lars, John C. Cheville, Andrew Evans, et al.. (2017). Pathology Imagebase—a reference image database for standardization of pathology. Histopathology. 71(5). 677–685. 17 indexed citations

13.

Wang, Qi, Ming Zhou, Ying Zhou, et al.. (2015). Effects of Carotid Endarterectomy on Cerebral Reperfusion and Cognitive Function in Patients with High Grade Carotid Stenosis: A Perfusion Weighted Magnetic Resonance Imaging Study. European Journal of Vascular and Endovascular Surgery. 50(1). 5–12. 23 indexed citations

14.

Yan, Xu, Ming Zhou, Jingjing Wang, et al.. (2014). Role of microRNA-27a in down-regulation of angiogenic factor AGGF1 under hypoxia associated with high-grade bladder urothelial carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(5). 712–725. 45 indexed citations

15.

Yang, Yixin, Qianjin Liao, Wei Fang, et al.. (2013). Correction: LPLUNC1 Inhibits Nasopharyngeal Carcinoma Cell Growth via Down-Regulation of the MAP Kinase and Cyclin D1/E2F Pathways. PLoS ONE. 8(8). 1 indexed citations

16.

Lauer, Scott, Ming Zhou, Viraj A. Master, & Adeboye O. Osunkoya. (2013). Chromophobe renal cell carcinoma with sarcomatoid differentiation. 35(2). 77–84. 2 indexed citations

17.

Huang, Dan, Yan Ding, Ming Zhou, et al.. (2010). Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma. Cancer Research. 70(3). 1063–1071. 330 indexed citations

18.

Han, Bo, Lei Wang, Javed Siddiqui, et al.. (2010). ETS Gene Aberrations in Atypical Cribriform Lesions of the Prostate. The American Journal of Surgical Pathology. 34(4). 478–485. 71 indexed citations

19.

Choueiri, Toni K., A. Plantade, Paul Elson, et al.. (2007). Efficacy of Sunitinib and Sorafenib in Metastatic Papillary and Chromophobe Renal Cell Carcinoma. Journal of Clinical Oncology. 26(1). 127–131. 311 indexed citations

20.

Roma, Andres A., Cristina Magi‐Galluzzi, & Ming Zhou. (2007). Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas. Archives of Pathology & Laboratory Medicine. 131(1). 122–125. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact